Nicolas J. Guzman - Publications

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial.

Journal: Lancet (London, England)

Published: August 29, 2025

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 02, 2025

The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.

Journal: Kidney international

Published: February 27, 2025

Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study.

Journal: BMJ open

Published: May 25, 2023

Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey.

Journal: Journal of patient experience

Published: April 15, 2022

Course of Hyperkalemia in Patients on Hemodialysis.

Journal: International journal of nephrology

Published: November 18, 2021

Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis

Published: May 04, 2021

Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia.

Journal: Kidney international reports

Published: April 30, 2021

Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients.

Journal: Kidney international reports

Published: April 27, 2021

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.

Journal: BMC nephrology

Published: March 23, 2021

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 23, 2020

Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China.

Journal: International journal of nephrology and renovascular disease

Published: November 10, 2020